Clinical Trial 43427

Garden Grove, CA 92845


Summary:

To evaluate the safety, tolerability, and response profile of NYX-783 in a Post-Traumatic Stress Disorder population.



Inclusion Criteria:

  • A primary diagnosis of PTSD (DSM-5 criteria, APA 2013) with the primary traumatic event occurring ≥12 months prior to screening.
  • PCL-5 ≥38 at screening.
    • CAPS-5 total score ≥30 at screening.


Qualified Participants May Receive:

Monetary compensation and study-related care at no cost to the participant.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.